Shandong Wit Dyne Health Overview
- Year Founded
-
1993

- Status
-
Public
- Employees
-
1,759

- Stock Symbol
-
000915

- Share Price
-
$4.65
- (As of Thursday Closing)
Shandong Wit Dyne Health General Information
Description
Shandong Wit Dyne Health Co Ltd is engaged in the pharmaceutical industry. The product portfolio includes Azithromycin Granules, Rosiglitazone Tartrate Tablets, Lanso (roxithromycin), Yi Kexin-over 1 year old among others.
Contact Information
Website
www.sd-wit.comCorporate Office
- Huate Plaza, No. 17703
- Jingshi Road
- Jinan, Shandong 250061
- China
Corporate Office
- Huate Plaza, No. 17703
- Jingshi Road
- Jinan, Shandong 250061
- China
Shandong Wit Dyne Health Stock Performance
As of 17-Jul-2025, Shandong Wit Dyne Health’s stock price is $4.65. Its current market cap is $1.09B with 234M shares.
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$4.65 | $4.61 | $3.33 - $5.09 | $1.09B | 234M | 5.67M | $0.31 |
Shandong Wit Dyne Health Financials Summary
As of 31-Mar-2025, Shandong Wit Dyne Health has a trailing 12-month revenue of $302M.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 695,512 | 707,298 | 728,737 | 1,369,519 |
Revenue | 302,420 | 297,471 | 351,125 | 347,622 |
EBITDA | 164,793 | 170,623 | 194,009 | 179,652 |
Net Income | 73,462 | 71,855 | 82,724 | 78,233 |
Total Assets | 709,938 | 675,462 | 733,332 | 679,851 |
Total Debt | 0 | 0 | 0 | 1,144 |
Shandong Wit Dyne Health Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Shandong Wit Dyne Health Signals
Shandong Wit Dyne Health ESG
Risk Overview
Risk Rating
Updated March, 01, 2025
36.41 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,697
Rank
Percentile

Pharmaceuticals
Industry
of 847
Rank
Percentile

Pharmaceuticals
Subindustry
of 420
Rank
Percentile

Shandong Wit Dyne Health FAQs
-
When was Shandong Wit Dyne Health founded?
Shandong Wit Dyne Health was founded in 1993.
-
Where is Shandong Wit Dyne Health headquartered?
Shandong Wit Dyne Health is headquartered in Jinan, China.
-
What is the size of Shandong Wit Dyne Health?
Shandong Wit Dyne Health has 1,759 total employees.
-
What industry is Shandong Wit Dyne Health in?
Shandong Wit Dyne Health’s primary industry is Pharmaceuticals.
-
Is Shandong Wit Dyne Health a private or public company?
Shandong Wit Dyne Health is a Public company.
-
What is Shandong Wit Dyne Health’s stock symbol?
The ticker symbol for Shandong Wit Dyne Health is 000915.
-
What is the current stock price of Shandong Wit Dyne Health?
As of 17-Jul-2025 the stock price of Shandong Wit Dyne Health is $4.65.
-
What is the current market cap of Shandong Wit Dyne Health?
The current market capitalization of Shandong Wit Dyne Health is $1.09B.
-
What is Shandong Wit Dyne Health’s current revenue?
The trailing twelve month revenue for Shandong Wit Dyne Health is $302M.
-
What is Shandong Wit Dyne Health’s annual earnings per share (EPS)?
Shandong Wit Dyne Health’s EPS for 12 months was $0.31.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »